Sigilon Therapeutics Inc logo

Sigilon Therapeutics Inc Share Price Today (NASDAQ: SGTX)

Sigilon Therapeutics Inc share price is $0 & ₹0.00 as on 9 Aug 2023 IST

▲

-22.47

(-100%)

Market is closed - opens 7 PM, 14 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 10 Aug 2023

View live Sigilon Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Sigilon Therapeutics Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Sigilon Therapeutics Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Sigilon Therapeutics Inc (SGTX) Key Statistics

in dollars & INR

Previous Close
$22.47
Open
$22.9
Market Capitalization
$57.5M
Today's Volume
$83.7K
Revenue TTM
$14.6M
EBITDA
$-36.2M
Earnings Per Share (EPS)
$-14.83
Dividend Yield
0.0%
Profit Margin
-253.33%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-75.77%

How to invest in Sigilon Therapeutics Inc Stock (SGTX) from India?

It is very easy for Indian residents to invest directly in Sigilon Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sigilon Therapeutics Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sigilon Therapeutics Inc or SGTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sigilon Therapeutics Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sigilon Therapeutics Inc shares which would translate to null fractional shares of Sigilon Therapeutics Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Sigilon Therapeutics Inc, in just a few clicks!

Global Institutional Holdings in Sigilon Therapeutics Inc

  • Flagship Ventures Management, Inc.

    31.88%

  • Canada Pension Plan Investment Board

    4.57%

  • FMR Inc

    3.24%

  • BlackRock Inc

    3.23%

  • Cercano Management LLC

    2.72%

  • Harbourvest Partners, LLC

    2.28%

Analyst Recommendation on Sigilon Therapeutics Inc

Rating
Trend

Buy

    66%Buy

    33%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Sigilon Therapeutics Inc(by analysts ranked 0 to 5 stars)

About Sigilon Therapeutics Inc

Sigilon Therapeutics, Inc., a preclinical stage biotechnology company, develops functional cures for patients with acute and chronic diseases. Its lead product candidate is SIG-002 to replace islet cells for the treatment of type 1 diabetes; and SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-205, SIG-218, SIG-220, and SIG-005, which are to treat the non-neurological manifestations of mucopolysaccharidosis type 1; and SIG-207 is to treat of Fabry disease. Sigilon Therapeutics, Inc. has a research collaboration and license agreement with Eli Lilly and Company for the development and commercialization of SLTx product candidates for the treatment of Type 1 Diabetes. The company was formerly known as Sigilon, Inc. and changed its name to Sigilon Therapeutics, Inc. in June 2017. Sigilon Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Organization
Sigilon Therapeutics Inc
Employees
62
CEO
Dr. Rogerio Vivaldi Coelho M.B.A., M.D., MBA
Industry
Miscellaneous

Important FAQs about investing in SGTX Stock from India :

Can Indians buy Sigilon Therapeutics Inc shares?

Yes, Indians can invest in the Sigilon Therapeutics Inc (SGTX) from India.

With INDmoney, you can buy Sigilon Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Sigilon Therapeutics Inc at zero transaction cost.

How can I buy Sigilon Therapeutics Inc shares from India?

It is very easy to buy Sigilon Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sigilon Therapeutics Inc (SGTX) be purchased?

Yes, you can buy fractional shares of Sigilon Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Sigilon Therapeutics Inc stocks?

To start investing in Sigilon Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Sigilon Therapeutics Inc?

Today's market capitalisation of Sigilon Therapeutics Inc SGTX is 57.5M

Who is the Chief Executive Officer (CEO) of Sigilon Therapeutics Inc ?

Dr. Rogerio Vivaldi Coelho M.B.A., M.D., MBA is the current Chief Executive Officer (CEO) of Sigilon Therapeutics Inc.